Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 129

1.

Dimerization of small integral membrane protein 1 promotes cell surface presentation of the Vel blood group epitope.

Kelley LP, Nylander A, Arnaud L, Schmoker AM, St Clair RM, Gleason LA, Souza JM, Storry JR, Olsson ML, Ballif BA.

FEBS Lett. 2019 Dec 26. doi: 10.1002/1873-3468.13726. [Epub ahead of print]

PMID:
31879955
2.

Automatic for the people: a rapidly evolving movement for the future of genotyping.

Storry JR, Jöud M, Olsson ML.

Transfusion. 2019 Nov;59(11):3545-3547. doi: 10.1111/trf.15561. Epub 2019 Oct 30. No abstract available.

PMID:
31667851
3.

A large deletion spanning XG and GYG2 constitutes a genetic basis of the Xgnull phenotype, underlying anti-Xga production.

Lee YQ, Storry JR, Karamatic Crew V, Halverson GR, Thornton N, Olsson ML.

Transfusion. 2019 May;59(5):1843-1849. doi: 10.1111/trf.15242. Epub 2019 Apr 2.

PMID:
30938838
4.

International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings.

Storry JR, Clausen FB, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Yanli J, Keller M, Lomas-Francis C, Nogues N, Olsson ML, Peyrard T, van der Schoot E, Tani Y, Thornton N, Wagner F, Weinstock C, Wendel S, Westhoff C, Yahalom V.

Vox Sang. 2019 Jan;114(1):95-102. doi: 10.1111/vox.12717. Epub 2018 Nov 12.

5.

International Forum on typing and matching strategies in patients on anti-CD38 monoclonal therapy.

De Vooght KMK, Lozano M, Bueno JL, Alarcón A, Romera I, Suzuki K, Zhiburt E, Holbro A, Infanti L, Buser A, Hustinx H, Deneys V, Frélik A, Thiry C, Murphy M, Staves J, Selleng K, Greinacher A, Kutner JM, Bonet Bub C, Castilho L, Kaufman RM, Colling ME, Perseghin P, Incontri A, Dassi M, Brilhante D, Macédo A, Cserti-Gazdewich C, Pendergrast JM, Hawes J, Lundgren MN, Storry JR, Jain A, Marwaha N, Sharma RR.

Vox Sang. 2018 Jun 26. doi: 10.1111/vox.12652. [Epub ahead of print] No abstract available.

PMID:
29947125
6.

Vox Sanguinis International Forum on typing and matching strategies in patients on anti-CD38 monoclonal therapy: summary.

de Vooght KMK, Lozano M, Bueno JL, Alarcón A, Romera I, Suzuki K, Zhiburt E, Holbro A, Infanti L, Buser A, Hustinx H, Deneys V, Frélik A, Thiry C, Murphy M, Staves J, Selleng K, Greinacher A, Kutner JM, Bonet Bub C, Castilho L, Kaufman R, Colling ME, Perseghin P, Incontri A, Dassi M, Brilhante D, Macêdo A, Cserti-Gazdewich C, Pendergrast JM, Hawes J, Lundgren MN, Storry JR, Jain A, Marwaha N, Sharma RR.

Vox Sang. 2018 May 20. doi: 10.1111/vox.12653. [Epub ahead of print] No abstract available.

PMID:
29781081
7.

Disruption of a GATA1-binding motif upstream of XG/PBDX abolishes Xga expression and resolves the Xg blood group system.

Möller M, Lee YQ, Vidovic K, Kjellström S, Björkman L, Storry JR, Olsson ML.

Blood. 2018 Jul 19;132(3):334-338. doi: 10.1182/blood-2018-03-842542. Epub 2018 May 10.

PMID:
29748255
8.

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of 36 blood group alleles among 396 Thai samples reveals region-specific variants.

Jongruamklang P, Gassner C, Meyer S, Kummasook A, Darlison M, Boonlum C, Chanta S, Frey BM, Olsson ML, Storry JR.

Transfusion. 2018 Jul;58(7):1752-1762. doi: 10.1111/trf.14624. Epub 2018 Apr 15.

PMID:
29656499
9.

More data needed to establish maternal breast milk IgG as cause for anti-D hemolytic disease of fetus and newborn.

Strauss RG, Storry JR.

Transfusion. 2018 Mar;58(3):828-829. doi: 10.1111/trf.14446. No abstract available.

PMID:
29528155
10.

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis.

Branch DR, Hellberg Å, Bruggeman CW, Storry JR, Sakac D, Blacquiere M, Tong TN, Burke-Murphy E, Binnington B, Parmar N, Riden LS, Willie K, Armali C, Aziz J, Lieberman L, Laroche V, Callum J, Lin Y, Shehata N, Pavenski K, Lau W, Hannach B, Kuijpers TW, Olsson ML, Cserti-Gazdewich C, Pendergrast J.

Blood. 2018 Feb 15;131(7):830-835. doi: 10.1182/blood-2017-07-796151. Epub 2018 Jan 5. No abstract available.

PMID:
29305554
11.

Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project.

Möller M, Jöud M, Storry JR, Olsson ML.

Blood Adv. 2016 Dec 16;1(3):240-249. doi: 10.1182/bloodadvances.2016001867. eCollection 2016 Dec 27.

12.

The Vel blood group system: a review.

Storry JR, Peyrard T.

Immunohematology. 2017 Jun;33(2):56-59. Review.

PMID:
28657763
13.

A and B antigen levels acquired by group O donor-derived erythrocytes following ABO-non-identical transfusion or minor ABO-incompatible haematopoietic stem cell transplantation.

Hult AK, Dykes JH, Storry JR, Olsson ML.

Transfus Med. 2017 Jun;27(3):181-191. doi: 10.1111/tme.12411. Epub 2017 Apr 12.

PMID:
28401678
14.

SMIM1 variants rs1175550 and rs143702418 independently modulate Vel blood group antigen expression.

Christophersen MK, Jöud M, Ajore R, Vege S, Ljungdahl KW, Westhoff CM, Olsson ML, Storry JR, Nilsson B.

Sci Rep. 2017 Jan 13;7:40451. doi: 10.1038/srep40451.

15.

FUT1 mutations responsible for the H-deficient phenotype in the Polish population, including the first example of an abolished start codon.

Michalewska B, Olsson ML, Naremska G, Walenciak J, Hult AK, Ozog A, Guz K, Brojer E, Storry JR.

Blood Transfus. 2018 Jan;16(1):101-104. doi: 10.2450/2016.0135-16. Epub 2016 Nov 21. No abstract available.

16.

International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings.

Storry JR, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Keller M, Lomas-Francis C, Moulds JM, Nogues N, Olsson ML, Peyrard T, van der Schoot CE, Tani Y, Thornton N, Wagner F, Wendel S, Westhoff C, Yahalom V.

ISBT Sci Ser. 2016 Aug;11(2):118-122. doi: 10.1111/voxs.12280. Epub 2016 Jun 27.

17.

A novel RHCE*02 allele, containing the single-nucleotide change c.460A>G, encodes weakened expression of C and e antigens.

Hellberg Å, Pesjak E, Karlsson J, Storry JR.

Transfusion. 2016 Sep;56(9):2391-2. doi: 10.1111/trf.13679. Epub 2016 Jun 10.

PMID:
27282785
18.

[Security laboratory facilitates the management of infections like Ebola].

Storry JR, Persson KE.

Lakartidningen. 2016 Feb 22;113. pii: DU3D. Swedish.

19.

Identification of the Molecular and Genetic Basis of PX2, a Glycosphingolipid Blood Group Antigen Lacking on Globoside-deficient Erythrocytes.

Westman JS, Benktander J, Storry JR, Peyrard T, Hult AK, Hellberg Å, Teneberg S, Olsson ML.

J Biol Chem. 2015 Jul 24;290(30):18505-18. doi: 10.1074/jbc.M115.655308. Epub 2015 Jun 8.

20.

RIFINs are adhesins implicated in severe Plasmodium falciparum malaria.

Goel S, Palmkvist M, Moll K, Joannin N, Lara P, Akhouri RR, Moradi N, Öjemalm K, Westman M, Angeletti D, Kjellin H, Lehtiö J, Blixt O, Ideström L, Gahmberg CG, Storry JR, Hult AK, Olsson ML, von Heijne G, Nilsson I, Wahlgren M.

Nat Med. 2015 Apr;21(4):314-7. doi: 10.1038/nm.3812. Epub 2015 Mar 9.

PMID:
25751816

Supplemental Content

Loading ...
Support Center